Revenue

Blockchain firm BTCS reports 290% revenue growth, pioneering a new model that blends DeFi with public markets to build an Ethereum powerhouse.

Wearable Devices and Rokid partner to bring touchless gesture control to smart glasses, promising a future where a flick of a finger runs your world.

CEO Joe Hayek will outline a strategy of M&A and innovation to boost value as the company navigates a complex market. Here’s what to expect.

A major HUD loan sale puts 2,500 occupied homes in the balance, pitting investor profits against the fate of non-borrowing family members.

The digital-native waterproof shoe brand Vessi opens its first U.S. store, blending online savvy with a physical footprint and community support.

Pharma giant Lilly and AI biotech BigHat are teaming up to solve a critical flaw in AI drug discovery, aiming to unlock a new generation of therapies.

Instead of selling out, the family-owned natural products giant is making its 1,800 employees owners, securing a legacy of independence and community focus.

Navan CEO Ariel Cohen will pitch his growth strategy at the Needham conference, a key test for the travel tech firm amid stock declines and high hopes.

With $16.4M in new funding, STRM.BIO is advancing a novel gene therapy platform that uses natural vesicles to target bone marrow, offering new hope for rare diseases.

Palisade Bio's PALI-2108, a drug targeting IBD at its source, secures a key investment, offering hope for a new era of treatment with fewer side effects.

A new global study shows consumers embrace AI for product research but don't trust it for purchases, revealing a 'Confidence Economy' ruled by transparency.

Blackstone is now the sole institutional backer of AIR Control Concepts, fueling the HVAC leader's rapid growth and strategic expansion into the booming data center market.

Formerly Pure Harvest, Mixie Technologies acquires a stake in digital twin firm HoloTwin, signaling a major strategic shift into AI and platform solutions.

Health tech firm IMVARIA, maker of an FDA-authorized AI for lung disease, has secured strategic funding from InHealth Ventures and Labcorp to expand its reach.

A new tri-specific antibody, IM1240, safely hits cancer cells at massive doses in preclinical studies, potentially solving a key toxicity problem in immunotherapy.

A new partnership gives NWS forecasters unprecedented views into weather blind spots, boosting warning capabilities for 130 million Americans.

A new patient app from BrightInsight and Sanofi reduced therapy discontinuation by 4%, proving digital tools can solve medicine's adherence problem.

From innovative liquid-cooled LCDs to premium laser TVs with Google TV, Formovie's latest projectors signal a major play for the entire home cinema market.

A new partnership aims to use advanced nuclear reactors to produce life-saving medical isotopes on U.S. soil, tackling a critical national vulnerability.

Fresh off its 'Fierce 15' win, Recludix Pharma and its billion-dollar Sanofi pact take the spotlight with a novel oral drug for inflammatory diseases.